Measles, mumps, and rubella vaccine

BIOLOGICAL5 trials

Sponsors

Sanofi Pasteur, a Sanofi Company, GlaxoSmithKline

Conditions

ChickenpoxDengueDengue Hemorrhagic FeverRSV ImmunizationYellow Fever

Phase 2

A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age

CompletedNCT05084508

GlaxoSmithKlineChickenpox

Start: 2022-02-03End: 2024-06-13Updated: 2025-02-28

Phase 3

Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers

CompletedNCT01411241

Sanofi Pasteur, a Sanofi CompanyDengue, Dengue Hemorrhagic Fever

Start: 2011-07-18End: 2014-04-30Updated: 2022-03-25

Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers

CompletedNCT01436396

Sanofi Pasteur, a Sanofi CompanyDengue, Dengue Hemorrhagic Fever, Yellow Fever

Start: 2011-09-07End: 2013-09-02Updated: 2022-03-25

Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

TerminatedNCT06397768

Sanofi Pasteur, a Sanofi CompanyRSV Immunization

Start: 2024-05-13End: 2025-09-18Updated: 2026-02-03

A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age

RecruitingNCT06693895

GlaxoSmithKlineChickenpox

Start: 2024-11-26End: 2026-11-23Target: 750Updated: 2025-01-20